Irving-based Biote Corp., which offers solutions in preventive healthcare through the delivery of personalized hormone therapy, has appointed Mary J. Puncochar as chief commercial officer.
Puncochar will lead Biote’s commercial initiatives to expand its presence in the growing market for hormone replacement therapy.
“Mary is a proven and dynamic leader who has substantial experience in managing teams, driving profitable growth and commercializing products aimed at enhancing patient health and wellness,” CEO Terry Weber said in a statement. “I believe Mary will be a tremendous asset to Biote as we expand our geographic presence, build our relationships with healthcare providers and continue to strengthen the Biote brand.”
Puncochar brings more than 30 years’ experience in sales, tech-enabled marketing and management roles at leading healthcare, pharmaceutical, and medical device companies.
Before Biote, she was head of the U.S. region at Ascensia Diabetes Care, a global diabetes care company, where she achieved commercial success through the development and launch of innovative solutions and precision tools aimed at helping consumers more effectively manage their health.
“It’s an honor to join Biote and advance the company’s mission of connecting healthcare providers and consumers to preventive treatments that are transforming healthy aging,” Puncochar said. “I’m excited to join Biote’s talented team during this time of growth and am eager to drive adoption of the Biote Method.”
Puncochar started her career as a healthcare provider at the University of Minnesota and has also held positions of increasing responsibility at companies including Bayer, Columbia Park Medical Group, InHome Services, and Honeywell.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Irving-based Biote Corporation, a preventive healthcare solutions provider that delivers personalized hormone therapy, has appointed John Denne as general manager of its men's health division. The move is aimed at expanding the company's presence in the growing market for male hormone replacement therapy. Biote, which was founded in 2012, went public on Nasdaq in May 2022 through a SPAC deal. Denne, a healthcare industry veteran with more than 30 years of experience in sales, business development, strategic marketing, and management, is expected to spearhead Biote's sales initiatives to fulfill a largely unmet medical need for millions of men seeking safe…
-
Pathlock's recent mergers, acquisitions, and capital raises have enabled the company to address the increasing risk in application security while establishing its leadership position as the industry's most complete 360-degree platform for application security and controls automation.
-
Yuvo Health, a New York-based technology-enabled administrative and managed-care solution provider for community health centers, announced Coppell executive Selase Dow as its new chief operating officer. Dow, who will remain based in the Dallas-Fort Worth city, brings more than two decades of managed care experience to the New York startup. Dow has worked closely with large physician organizations in North Texas to implement financial and care models and has a deep background in operations, ACO management, contracting, and more. Yuvo Health is a New York-based startup founded in 2021 by a BIPOC founding team. The company aims to provide administrative…
-
Dallas-based EnLink Midstream LLC announced that Benjamin D. Lamb has been appointed executive vice president and chief financial officer (CFO) and that Walter Pinto was appointed executive vice president and chief operating officer. In a move related to these appointments, EnLink said that its commercial and business development teams, previously overseen by the COO, will be led by a chief commercial officer to be hired from outside of EnLink. The company said that the CCO will join the EnLink executive leadership team and will focus on strategically growing its strong gathering and processing segments alongside its new carbon capture transportation…
-
Misti Meggs, Mohr Partners' new CCO, built the company's research, site-selection, and consulting services platforms to be "best in class" during her 16 year tenure. The services have been critical in providing corporate real estate advice to mid-cap and Fortune 500 companies, focusing on labor, logistics, incentives, and workplace strategy, says Mohr Partners Chairman and CEO Robert Shibuya.
